Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Non-Current Debt (2018 - 2021)

Lipocine (LPCN) has disclosed Non-Current Debt for 4 consecutive years, with $1.4 million as the latest value for Q1 2021.

  • For the quarter ending Q1 2021, Non-Current Debt fell 69.23% year-over-year to $1.4 million, compared with a TTM value of $1.4 million through Mar 2021, down 69.23%, and an annual FY2020 reading of $2.3 million, down 40.83% over the prior year.
  • Non-Current Debt was $1.4 million for Q1 2021 at Lipocine, down from $2.3 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $8.7 million in Q1 2018 and bottomed at $1.4 million in Q1 2021.
  • Average Non-Current Debt over 4 years is $5.2 million, with a median of $4.7 million recorded in 2020.
  • The sharpest move saw Non-Current Debt fell 23.9% in 2020, then tumbled 69.23% in 2021.
  • Year by year, Non-Current Debt stood at $6.9 million in 2018, then crashed by 44.93% to $3.8 million in 2019, then plummeted by 40.83% to $2.3 million in 2020, then tumbled by 36.09% to $1.4 million in 2021.
  • Business Quant data shows Non-Current Debt for LPCN at $1.4 million in Q1 2021, $2.3 million in Q4 2020, and $3.2 million in Q3 2020.